Angela R Melton-Celsa (Angela Melton-Celsa)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Induced Pluripotent Stem Cells

Endoplasmic Reticulum

High Fat Diet Induced

Top Venues

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Bowser, Angela R Melton-Celsa, Itziar Chapartegui-González, Alfredo G Torres
Further Evaluation of Enterohemorrhagic Escherichia coli Gold Nanoparticle Vaccines Utilizing Citrobacter rodentium as the Model Organism. Vaccines 12 (5) (2024)
Sarah Bowser, Angela R Melton-Celsa, Itziar Chapartegui-González, Alfredo G Torres
Further Evaluation of Enterohemorrhagic Escherichia coli Gold Nanoparticle Vaccines Utilizing Citrobacter rodentium as the Model Organism. Vaccines 12 (5) (2024)
Rama R Atitkar, Angela R Melton-Celsa
Differences in the Shiga Toxin (Stx) 2a Phage Regulatory Switch Region Influence Stx2 Localization and Virulence of Stx-Producing Escherichia coli in Mice. Microorganisms 11 (8) (2023)
Rebecca L Lindsey, Arjun Prasad, Michael Feldgarden, Narjol Gonzalez-Escalona, Curtis J Kapsak, William Klimke, Angela R Melton-Celsa, Peyton Smith, Alexandre Souvorov, Jenny Truong, Flemming Scheutz
Identification and Characterization of ten Escherichia coli Strains Encoding Novel Shiga Toxin 2 Subtypes, Stx2n as Well as Stx2j, Stx2m, and Stx2o, in the United States. Microorganisms 11 (10) (2023)
Rebecca A Bova, Angela R Melton-Celsa
Shiga toxin (Stx) type 2-induced increase in O-linked N-acetyl glucosamine protein modification: a new therapeutic target? EMBO molecular medicine 14 (1) (2021)